Regulation of Toll-like receptor signaling by NDP52-mediated selective autophagy is normally inactivated by A20 by Inomata, Megumi et al.
RESEARCH ARTICLE
Regulation of Toll-like receptor signaling by NDP52-mediated
selective autophagy is normally inactivated by A20
Megumi Inomata • Shumpei Niida •
Ken-ichiro Shibata • Takeshi Into
Received: 18 April 2011/Revised: 21 August 2011/Accepted: 6 September 2011/Published online: 2 October 2011
 The Author(s) 2011. This article is published with open access at Springerlink.com
Abstract Toll-like receptor (TLR) signaling is linked to
autophagy that facilitates elimination of intracellular patho-
gens. However, it is largely unknown whether autophagy
controls TLR signaling. Here, we report that poly(I:C)
stimulation induces selective autophagic degradation of the
TLR adaptor molecule TRIF and the signaling molecule
TRAF6, which is revealed by gene silencing of the ubiq-
uitin-editing enzyme A20. This type of autophagy induced
formation of autophagosomes and could be suppressed by
an autophagy inhibitor and lysosomal inhibitors. However,
this autophagy was not associated with canonical auto-
phagic processes, including involvement of Beclin-1 and
conversion of LC3-I to LC3-II. Through screening of
TRIF-interacting ‘autophagy receptors’ in human cells, we
identiﬁed that NDP52 mediated the selective autophagic
degradation of TRIF and TRAF6 but not TRAF3. NDP52
was polyubiquitinated by TRAF6 and was involved in
aggregation of TRAF6, which may result in the selective
degradation. Intriguingly, only under the condition of A20
silencing, NDP52 could effectively suppress poly(I:C)-
induced proinﬂammatory gene expression. Thus, this study
clariﬁes a selective autophagic mechanism mediated
by NDP52 that works downstream of TRIF–TRAF6. Fur-
thermore, although A20 is known as a signaling ﬁne-tuner
to prevent excess TLR signaling, it paradoxically down-
regulates the ﬁne-tuning effect of NDP52 on TLR
signaling.
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Abbreviations
CC Coiled-coil
GFP Green ﬂuorescent protein
IFN Interferon
IRAK IL-1 receptor-associated kinase
LIM Lin11, Isl-1 and Mec-3
qRT-PCR Quantitative reverse transcription-coupled
PCR
PI3 Phosphatidylinositol 3
SKICH Skeletal muscle and kidney-enriched inositol
phosphatase carboxyl homology
Introduction
Toll-like receptors (TLRs) play a critical role in triggering
of various innate immune responses associated with both
physiological and pathological immunity. After recognition
of pathogen-associated molecular patterns or danger-asso-
ciated endogenous molecules, TLRs activate signaling
through recruitment of two key adaptor molecules, termed
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123myeloid differentiation factor 88 (MyD88) and Toll/inter-
leukin (IL)-1 receptor homology domain-containing adaptor
inducing interferon (IFN)-b (TRIF; also called TICAM-1)
[1, 2]. MyD88 is a universal signaling adaptor for all TLR
members except for TLR3, whereas TRIF is a unique
signaling adaptor only for TLR3 and TLR4.
It is currently well understood that TLR signal trans-
duction is largely dependent on functioning of speciﬁc E3
ubiquitin ligases. After TLR engagement, MyD88 facili-
tates recruitment of IRAK-4 followed by IRAK-1/2,
forming the ‘Myddosome’ signaling complex [3]. This
complex then interacts with the E3 ubiquitin ligase
TRAF6 that functions as a signaling scaffold to catalyse
Lys63-linked polyubiquitination (polyUb) of target pro-
teins, including IRAK-1 [4], or synthesis of free Lys63-
linked polyubiquitin chains [5]. These ubiquitin chains
bind to TAB2 and TAB3 to activate the TAK1 complex
a n db i n dt oN E M Ot oa c t i v a t et h eI K Kc o m p l e x ,b o t ho f
which are crucial for NF-jB activation [1, 5, 6]. TRIF is
able to directly activate TRAF6-dependent NF-jBs i g -
naling [1, 7]. In addition, TRIF activates the E3 ubiquitin
ligase TRAF3 that catalyses Lys63-linked polyUb of
TBK1 and IKKi/IKKe, which mediates phosphorylation
of IRF3 and its nuclear translocation to produce type I
IFNs [1, 7–9]. Although TRAF3 is also incorporated into
the MyD88 complex [8], MyD88 activates the E3 ubiq-
uitin ligases cIAP1/2 to facilitate TRAF3 Lys48-linked
polyUb followed by proteasomal degradation, which do
not work for TRIF-mediated signaling [10]. TRIF also
recruits RIP1 to the C-terminal RIP homotypic interaction
motif [11]. RIP1 undergoes Lys63-linked polyUb by the
E3 ubiquitin ligase Peli1 to activate NF-jB signaling
[12].
Excessive activation of TLR-mediated responses
accumulates pathological damages, ultimately leading to
the development of inﬂammatory disorders [13]. To
obviate this, cells normally employ regulatory mecha-
nisms for ‘ﬁne-tuning’ of TLR signaling. The ubiquitin-
editing enzyme A20 (also known as TNFAIP3) cleaves
Lys63-linked polyubiquitin chains and promotes Lys48-
linked polyUb [14], leading to negative regulation of
TLR-mediated activation of NF-jB and/or IRF3 through
regulation of its substrates, including TRAF6, TRAF3
a n dR I P 1[ 15, 16]. In addition, the E3 ubiquitin ligase
Cbl-b degrades Syk-phosphorylated MyD88 and TRIF
through catalysing Lys48-linked polyUb [17]. Lys48-
linked polyUb is known to target substrates for prote-
asomal degradation [18, 19], while Lys63-linked polyUb
is involved in the selective removal of target proteins by
autophagy [20, 21].
Recent ﬁndings have revealed that TLRs utilize the
mechanism of autophagy to eliminate intracellular patho-
gens [22–24]. The term autophagy is broadly used to
designate the lysosomal delivery and degradation of
intracellular components. The best-known form of
autophagy is macroautophagy, a process of bulk lyso-
s o m a ls e l f - d i g e s t i o ni nr e s p onse to nutrient starvation and
other metabolic stresses, induction of which consists of
the processes of autophagosome vesicle nucleation by
Beclin1 in complex with the class III phosphatidylinositol
3 (PI3) kinase VPS34, and then vesicle elongation by the
covalent conjugation of the ATG proteins and LC3 to
form the autophagosome [25, 26]. However, recent
reports have revealed the existence of various types of
autophagy that can be induced through both canonical
and non-canonical processes [27–29]. Furthermore, dur-
ing the process called ‘selective autophagy’, cytoplasmic
constituents with Lys63-linked polyUb, including mis-
folded proteins, damaged organelles and intracellular
pathogens, are clustered within the autophagosome by
autophagy-associated ubiquitin receptors (hereafter
autophagy receptors), such as sequestosome 1 (SQSTM1;
also known as p62), followed by delivery to the lysosome
to selectively degrade unnecessary proteins or organelles
[21, 30].
In this study, we report that gene silencing of A20
revealed an unknown mechanism of selective autophagic
degradation of TRIF, the process of which is promoted by
the autophagy receptor nuclear dot protein (NDP) 52.
NDP52 has recently been identiﬁed as an autophagy
receptor recognizing ubiquitin-coated cytosolic bacteria
[31]. Interestingly, under the condition of A20 silencing,
NDP52 could exert an effective downregulatory effect on
expression of TLR-induced proinﬂammatory genes. Thus,
this study provides novel information regarding the selec-
tive autophagy downstream of TLRs, which has a ‘ﬁne-
tuning’ effect on TLR signaling but is normally inactivated
by the ﬁne-tuner A20.
Materials and methods
Reagents and antibodies
Synthetic poly(I:C) (polyriboinosinic polyribocytidylic
acid) was obtained from Amersham. Highly puriﬁed
Escherichia coli lipopolysaccharide (LPS) was as descri-
bed previously [32]. Z-VAD-fmk was obtained from
Zymed Laboratories. The class III PI3 kinase inhibitor
3-methyladenine (3-MA), the lysosomal thiol protease
inhibitor E-64, the aspartic protease inhibitor pepstatin A,
the cysteine protease leupeptin, and etoposide were pur-
chased from Sigma-Aldrich. MG-132 was obtained from
Calbiochem. The vacuolar proton-ATPase inhibitor ba-
ﬁlomycin A1 was obtained from Wako Chemical. Lithium
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123dodecyl sulfate (LDS) sample buffer was obtained from
Invitrogen. Sources of antibodies used are: anti-TRIF
rabbit polyclonal antibody (Alexis; AL227), anti-BAG3
rabbit polyclonal antibody (Abcam; ab86298), anti-
BNIP3L (NIX) rabbit polyclonal antibody (Abcam;
ab8399), anti-NDP52 (CALCOCO2) rabbit polyclonal
antibody (Abcam; ab68588), anti-Flag M2 monoclonal
antibody (Sigma-Aldrich; F3165), anti-LC-3 monoclo-
nal antibody (MBL; M115-2), anti-Lys63-linked
polyUb rabbit monoclonal antibody Apu3 (Millipore;
05-1308), anti-Lys48-linked polyUb rabbit monoclonal
antibody Apu2 (Millipore; 05-1307), FK2 anti-polyUb
antibody (Nippon Biotest; MFK-004), anti-NBR1 rabbit
polyclonal antibody (Cell Signaling Technology;
5202), anti-GFP rabbit monoclonal antibody (Cell
Signaling Technology; 2956) and anti-Rab7 rabbit
monoclonal antibody (Cell Signaling Technology;
9367). In addition, rabbit polyclonal antibodies to
TRAF6 (sc-7221), TRAF3 (sc-948), RIP1 (sc-7881),
SQSTM1 (sc-25575), HDAC6 (sc-11420), Beclin-1
(sc-11427), A20 (sc-22834), HA (sc-805), GAPDH
(sc-25778) and b-actin (SC-8432) were obtained from
S a n t aC r u zB i o t e c h n o l o g y .
Cell culture
HeLa cells and human embryonic kidney (HEK) 293T
cells were maintained at 37C in a humidiﬁed atmosphere
of 5% CO2 in DMEM supplemented with 10% FBS,
penicillin G (100 units/ml), and streptomycin (100 lg/
ml). HEK293 cells stably transfected with human TLR4,
MD2 and CD14 genes (HEK293-TLR4/MD2-CD14 cells)
were obtained from Invivogen and grown in DMEM sup-
plemented with blasticidin (10 lg/ml) and hygromycin B
(50 lg/ml). Cells were stimulated with LPS in antibiotic-
free DMEM supplemented with 5% FBS. Human bone
marrow-derived primary mononuclear cells were obtained
from Lonza (2M-125C). These cells were cultured in
Iscove’s modiﬁed Dulbecco’s medium (IMDM) supple-
mented with 15% FBS, penicillin G (100 units/ml) and
streptomycin (100 lg/ml) for 2 h before transfection of
siRNA.
DNA constructs
Constructs encoding N-terminally Flag-tagged TRIF
(Flag-TRIF) and N-terminally hemagglutinin (HA)-tag-
ged NDP52 (HA-NDP52) were generated by amplifying
cDNA of THP-1 cells and by subcloning them into
pcDNA3.1/V5-His (Invitrogen). SKICH domain-deleted
HA-NDP52 (HA-NDP52 DSKICH), LIM-like domain-
deleted HA-NDP52 (HA-NDP52 DLIM-L), and both
SKICH and LIM-like domain-deleted HA-NDP52
(HA-NDP52 CC) were generated using a QuikChange II
site-directed mutagenesis kit (Stratagene) according to
the manufacturer’s instructions. Expression plasmids for
N-terminally Flag-tagged MyD88 and N-terminally HA-
tagged SQSTM1 were as described previously [33].
Expression plasmids of N-terminally Flag-tagged
TRAF6 and C-terminally Flag-tagged TRAF3 were kind
gifts from Dr. H. Nakano (Juntendo University, Tokyo,
Japan) and Dr. M. Matsumoto (Hokkaido University,
Sapporo, Japan), respectively. The expression plasmid
of GFP-tagged LC3 [30] was kindly provided by
Prof. T. Johansen (University of Tromso ¨,T r o m s o ¨,
Norway). Transfection of plasmids into HeLa cells and
HEK293T cells was performed using Lipofectamine
2000 reagent (Invitrogen) according to the manufacturer’s
instructions.
siRNA and gene silencing
ON-TARGET plus SMARTpool small interference RNA
(siRNA) against human NDP52 (CALCOCO2, L-010637-
00-0005), human A20 (TNFAIP3, L-009919-00-0005)
and human Beclin-1 (BECN1, L-010552-00-0005) were
purchased from Dharmacon as well as the control ON-
TARGET plus non-targeting siRNA pool (D-001810-01).
ON-TARGET plus SMARTpool siRNA consist of four
distinct RNA oligoduplexes per target gene. The ON-
TARGET plus non-targeting siRNA pool also consists of
four distinct control RNA oligoduplexes. For transfection
of siRNA, HeLa cells and HEK293T cells were washed
once with Opti-MEM I medium (Invitrogen), and then
transfection of siRNA (100 nM) was performed with
Lipofectamine RNAi MAX reagent (Invitrogen) as
instructed by the manufacturer (1 ll per 20 pmol of siRNA
being used). After 12 h of incubation, culture media were
changed to DMEM supplemented with 5% FBS, and
incubation was continued for a further 12 h. Human bone
marrow-derived primary mononuclear cells (4 9 10
6) were
transfected with siRNA (30 nM) using the Nucleofector 2b
electroporator (Amaxa) and the accessory program Y-001.
Then, the cells were maintained in IMDM supplemented
with 50 ng/ml M-CSF, 15% FBS, penicillin G and strep-
tomycin for 48 h. For prolonged gene silencing, HeLa cells
seeded on 6-well plates were transfected with siRNAs
using Lipofectamine 2000 reagent. After 12 h of incuba-
tion, culture media were changed to DMEM supplemented
with 10% FBS, and incubation was continued for a further
24 h. Then the cells were split 1–2 into another 6-well plate
and cultured for 12 h. These procedures were further
repeated twice. After 144 h (6 days), cells were used for
the experiments.
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Total RNA was prepared from cells using a GenElute
mammalian total RNA miniprep kit (Sigma-Aldrich). One
lg of total RNA was reverse-transcribed using Rever-
TraAce reverse transcriptase (TOYOBO) with both an
oligo21dT primer and random hexamer primers. qRT-
PCR was performed using SYBR Premix Ex Taq (Ta-
KaRa) on a thermal cycler dice real-time system TP800
(TaKaRa), according to the manufacturer’s instructions.
All of the primer sets used in this study were obtained
from TaKaRa. We conﬁrmed that there was no critical
difference between the values normalized to the levels of
each of four different house-keeping genes, ACTB,
GAPDH, HPRT1 and PPIA. Results shown were nor-
malized to the level of ACTB and are representative of
three independent experiments.
Immunoprecipitation
For immunoprecipitation (IP) of Flag-tagged proteins,
HEK293T cells seeded on 10-cm culture dishes or 6-well
plates were lysed with 880 or 250 llo ft h el y s i sb u f f e r
[33]a t4 C for 15 min. After clariﬁcation by cen-
trifugation at 15,000g for 10 min, cell lysates were
immunoprecipitated using 75 or 25 ll anti-Flag M2 aga-
rose (Sigma-Aldrich) for 1 h at 4C on a rotating platform.
For IP of HA epitope tag, HEK293T cells seeded on
6-well plates were lysed with 250 ll of lysis buffer. After
clariﬁcation, cell lysates were immunoprecipitated using
25 ll EZview Red Anti-HA Afﬁnity Gel (Sigma-Aldrich).
The beads were washed four times with 1 ml lysis buffer,
boiled with SDS sample buffer containing 2-mercap-
toethanol, and subjected to immunoblotting (IB) using the
indicated antibodies. Results are representative of three
independent experiments.
Immunoblotting
HeLa cells and HEK293T cells seeded on 6-well plates
were lysed with 300 ll of the lysis buffer [33]a t4 Cf o r
15 min. Lysates were boiled with SDS sample buffer. In
some experiments, HEK293T cells seeded on 6-well
plates were lysed with 300 llo fL D SS a m p l eB u f f e ra t
4Cf o r1 5 m i n ,a n dt h e nt h el y s a t e sw e r eb o i l e df o r
5 min. Lysates were separated on 10–20% gradient SDS-
PAGE and transferred to Immobilon-P transfer mem-
branes (Millipore). The membranes were blocked in 5%
skim milk in PBS. Immunoreactive bands were detected
using the antibodies described above. The ECL Plus
Western Blotting detection system (Amersham Biosci-
ence) was used to visualize the blots on an ECL
minicamera (Amersham Bioscences) with the instant
black and white ﬁlm FP-3000B (Fuji Films). Results are
representative of three independent experiments. Densi-
tometric analyses were performed as described previously
[33].
Luciferase reporter gene assay
HEK293T cells seeded on 24-well plates were transfected
with either 50 ng of an NF-jB-driven ﬁreﬂy luciferase
reporter plasmid (pNF-jB-Luc; Stratagene) or an IRF3-
driven ﬁreﬂy luciferase reporter plasmid (p561-luc,
kindly provided by Prof. X. Li, Cleveland Clinic Foun-
dation, Ohio, USA) together with 5 ng of a construct
directing expression of Renilla luciferase under the con-
trol of a constitutively active thymidine kinase promoter
(pRL-TK; Promega) and different expression vectors for
24 h. HEK293-TLR4/MD2-CD14 cells seeded on 24-well
plates were transfected with either pNF-jB-Luc or p561-
luc together with pRL-TK for 18 h and were then treated
with 100 ng/ml LPS for 6 h. The cells were lysed and
luciferase activity was measured as described previously
[32].
Immunoﬂuorescent microscopy and image analysis
For immunoﬂuorescence microscopy, cells were seeded on
Lab-Tek chamber 8-well permanox slides (Nunc) and ﬁxed
at -20C with methanol for 20 min. Double-immuno-
staining was then carried out using the primary antibody
and the secondary Alexa488-conjugated antibody (Invit-
rogen) and then with the tertiary antibody and the fourth
Alexa564-conjugated antibody (Invitrogen). Stained cells
were embedded in Mowiol 4-88 (Calbiochem) in the
presence of the Prolong Gold Antifade reagent (Invitro-
gen). Fluorescent images were obtained as described
previously [33]. Cell quantiﬁcation was carried out by
counting cells on ﬁve merged images of microscopic ﬁelds
including at least 30 TRAF6-positive cells scored. Results
are representative of three separate experiments and
expressed as the mean ± SD (n = 5).
Electron microscopic analysis
For electron microscopy, human bone marrow-derived
primary mononuclear cells or HeLa cells were ﬁxed with
2% glutaraldehyde in a 0.1-M phosphate buffer (pH 7.4) at
4C. They were post-ﬁxed with an aqueous solution of 2%
OsO4. Then, the specimens were dehydrated in a graded
ethanol and embedded in Epon 812. Ultrathin sections were
stained with uranyl acetate and lead citrate for observation
under a JEM1200EX electron microscope (Jeol). The area
of every autophagic vacuole (including autophagosome)
966 M. Inomata et al.
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photographs with the use of a planimeter (Planix). For each
cell, the autophagic area was calculated by expressing the
total area of autophagic vacuoles as a percentage of the
cytoplasmic area.
Statistical analysis
Data are expressed as mean ± SD (n = 3). P values were
calculated by Student’s t test and one-way analysis of
variance and were considered signiﬁcant at levels of\0.05
or\0.01.
Results
Gene silencing of A20 reveals a mechanism
of degradation of TRIF and TRAF6
Human epithelial HeLa cells are generally thought to hypo-
respondtostimuliofTLRsbecauseoflowexpressionlevelsof
TLRs[34,35].HeLacellscouldweaklyrespondtotheTLR3-
stimulantligandpoly(I:C)toinducemRNAexpressionofIL-
6 and IL-8 (Fig. 1a). Expression of A20 mRNA was also
increasedafterpoly(I:C)stimulation(Fig. 1a).GiventhatA20
isapotentsuppressorofTLRsignaling,weexaminedwhether
A20 has regulatory effects on poly(I:C)-induced responses.
Silencing of A20 by short-term transfection of siRNA
revealed that the responsiveness of HeLa cells to poly(I:C)
wasrestrictedbyA20(Fig. 1a).ThelevelofTRIFproteinwas
found to be decreased after poly(I:C) stimulation under the
condition of A20 silencing (Fig. 1b) although TRIF mRNA
was unchanged (Fig. 1a). In addition, among three major
signaling mediators downstream of TRIF (TRAF6, TRAF3
andRIP1),onlyTRAF6wasclearlydecreasedafterpoly(I:C)
stimulation (Fig. 1b). At least expression level of GAPDH
protein was not decreased (Fig. 1b). Theseobservationswere
also found in HeLa cells under the condition of long-term
silencing of A20 (Fig. 1c). Also, the poly(I:C)-induced
decrease of TRIF and TRAF6 was observed in human bone
marrow-derived primary mononuclear cells transfected with
A20 siRNA (Fig. 1d).
In contrast to endogenous TRIF, transfected TRIF
automatically activates downstream signaling in a TLR
stimulus-independent manner [36]. In HEK293T cells
transfected with TRIF, the level of TRIF protein was found
to be decreased by silencing of A20 (Fig. 1e). Accompa-
nying this, endogenous TRAF6, but not TRAF3 and RIP1,
was clearly decreased (Fig. 1e). These results indicate
that A20 has a potential to conceal the selective decrease
of TRIF and TRAF6 after TRIF-dependent signal
transduction.
TRIF and TRAF6 are degraded by a machinery
of non-canonical autophagy
We next investigated what machinery is involved in the
selective decrease of TRIF and TRAF6. TRIF was previ-
ously reported to undergo proteolytic cleavage by caspases
[37]. However, the poly(I:C)-induced decrease of TRIF and
TRAF6 in A20-silenced HeLa cells was not affected by
treatment with the pan-caspase inhibitor Z-VAD-fmk
(Fig. 2a). Generally, eukaryotic cells utilize the ubiquitin-
26S proteasome system and autophagy as the major protein
degradation pathways. Importantly, treatment of A20-
silenced HeLa cells with the autophagy inhibitor 3-MA, but
not the 26S proteasome inhibitor MG-132, could inhibit the
decrease of TRIF and TRAF6 (Fig. 2b). In HEK293T cells,
3-MA treatment obviously increased the level of overex-
pressed TRIF and endogenous TRAF6, whereas MG-132
conversely decreased these levels (Fig. 2c). As inhibition
of the proteasome was reported to promote autophagy [38],
activated TRIF and TRAF6 may be preferentially degraded
by autophagy. Furthermore, the decrease of TRIF and
TRAF6 in A20-silenced HeLa cells was also suppressed by
the lysosomal protease inhibitors E-64, pepstatin A and
leupeptin, and the lysosomal vacuolar H
?-ATPase inhibitor
baﬁlomycin A1 (Fig. 2d). We also investigated whether
poly(I:C) stimulation induces formation of autophagic
vacuoles in A20-silenced human bone marrow mononu-
clear cells. The autophagy-inducer etoposide clearly
promoted formation of autophagic vacuoles in human bone
marrow mononuclear cells (Supplementary material,
Fig.S1).Someofautophagicvacuolesweredouble-membrane
structures indicative of autophagosomes (Supplementary
material, Fig. S1). In A20-silenced human bone marrow
mononuclear cells, poly(I:C) increased formation of auto-
phagic vacuoles (Fig. 2e). Poly(I:C)-induced formation of
autophagic vacuoles were also observed in A20-silenced
HeLa cells (data not shown). These results indicate that
TRIF and TRAF6 are degraded within lysosomes through
autophagic processes.
We further investigated the involvement of canonical
autophagic processes in the decrease of TRIF and
TRAF6. Generally, conversion of normal LC3 (LC3-I) to
the phosphatidylethanolamine-conjugated form (LC3-II)
is thought of as a hallmark response of canonical
autophagy ﬂux [39]. In HeLa cells, we could observe
conversion of LC3-I to LC3-II after treatment of cells
with baﬁlomycin A1 (Supplementary material, Fig. S2).
However, poly(I:C) stimulation did not affect LC3 con-
version at all (Fig. 2f). Furthermore, in A20-silenced
HeLa cells, basal LC3 conversion was slightly promoted,
but poly(I:C) did not promote the conversion (Fig. 2f).
Also, poly(I:C) stimulation did not affect transfected
GFP-tagged LC3 (GFP-LC3) in HeLa cells (Fig. 2g). We
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autophagy. Silencing of Beclin-1 by siRNA did not affect
the decrease of TRIF and TRAF6 after poly(I:C) stimu-
lation in A20-silenced HeLa cells (Fig. 2h). Also, neither
silencing of ATG5 nor of ATG7 affected these decreases
(data not shown). Thus, our results collectively suggest
that TRIF and TRAF6 are selectively degraded by non-
canonical autophagy that is thought to be normally
inactivated by A20.
Recruitment of autophagy receptors to TRIF
To our knowledge, any mechanisms for selective auto-
phagic degradation of TRIF have not been clariﬁed.
However, given that selective autophagic degradation of
proteins is recently suggested to be mediated by autophagy
receptors [21], it is possible that the degradation of TRIF is
mediated by speciﬁc autophagy receptors. To test whether
or not TRIF interacts with autophagy receptors, we
immunoprecipitated the Flag-tagged version of TRIF
expressed in HEK293T cells followed by immunoblot
analyses of endogenous co-immunoprecipitated molecules.
In this experiment, TRAF6, TRAF3 and RIP1 could be
detectable (Fig. 3a), indicating that immunoprecipitated
TRIF forms signaling complexes. We therefore screened
the established autophagy receptors, SQSTM1 [40–42],
NBR1 [43], NIX/BNIP3L [44], HDAC6 [45], BAG3 [46]
and NDP52 [31]. As a result, interestingly, only NDP52
was detectable (Fig. 3a). Moreover, in HEK293T cells, we
could observe interaction of TRIF with NDP52 by
cotransfection of differently tagged versions followed by IP
and IB (Fig. 3b). Thus, activated TRIF recruits the
autophagy receptor NDP52, which may mediate the
selective degradation of activated TRIF.
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Fig. 1 A20 conceals the mechanism of degradation of TRIF and
TRAF6 by autophagy. a HeLa cells were transfected with control
siRNA or A20 siRNA for 24 h. Cells were then stimulated with
50 lg/ml poly (I:C) for 6 h. The mRNA levels of IL-6, IL-8, A20 and
TRIF were determined by qRT-PCR. Data are expressed as the mean
fold induction ±SD (n = 3) relative to control levels (Control siRNA,
Medium), for representative of three independent experiments.
*P\0.01, for comparison with the Control siRNA group. b HeLa
cells were transfected with control siRNA or A20 siRNA for 24 h.
Cells were then stimulated with 50 lg/ml poly (I:C) for the indicated
periods. Cell lysates were analyzed by IB with antibodies to TRIF,
TRAF6, TRAF3, RIP1, A20 and GAPDH. c HeLa cells were
repetitively transfected with control siRNA or A20 siRNA for three
times during 6 days. Cells were then stimulated with 50 lg/ml poly
(I:C) for 6 h. Cell lysates were analyzed by IB with antibodies to
TRIF, TRAF6, TRAF3, RIP1, A20 and GAPDH. d Human bone
marrow-derived primary mononuclear cells were transfected with
control siRNA or A20 siRNA and incubated in medium supplemented
with 50 ng/ml M-CSF for 48 h. Cells were then stimulated with
50 lg/ml poly(I:C) for 6 h. Cell lysates were analyzed by IB with
antibodies to TRIF, TRAF6, TRAF3, RIP1, A20 and GAPDH.
e HEK293T cells were transfected with control siRNA or A20 siRNA
for 24 h. Cells were further transfected with Flag-TRIF for 18 h. Cell
lysates were then analyzed by IB with antibodies to Flag epitope,
TRAF6, TRAF3, RIP1, A20 and GAPDH. All results are representa-
tive of three independent experiments
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through autophagy
We next investigated whether NDP52 is indeed
involved in TRIF degradation after poly(I:C) stimulation
in A20-silenced HeLa cells. Importantly, silencing
of NDP52 by siRNA signiﬁcantly restored poly(I:C)-
induced degradation of TRIF (Fig. 4a). Furthermore,
overexpression of TRIF with NDP52 in HEK293T cells
revealed that NDP52 could degrade TRIF, and the
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TRAF6, TRAF3 and GAPDH. c HEK293T cells were transfected with
Flag-TRIF for 18 h. Cells were then treated with either 20 lM MG-
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Baﬁlomycin A1 for 4 h. Then cells were stimulated with 50 lg/ml
poly (I:C) for 6 h. Cell lysates were analyzed by IB with antibodies to
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primary mononuclear cells were transfected with A20 siRNA and
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were assessed by electron microscopy. Arrows autophagic vacuoles.
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magniﬁcation, 93,000. Error bars ±SD (n = 5). *P B 0.01.
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GAPDH. h HeLa cells were transfected with A20 siRNA together
with control siRNA or Beclin-1 siRNA for 24 h. Cells were then
stimulated with 50 lg/ml poly (I:C) for the indicated periods. Cell
lysates were analyzed by IB with antibodies to TRIF, TRAF6, TRAF3,
Beclin-1 and GAPDH
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123degradation was restored by treatment with 3-MA
(Fig. 4b).
There is some doubt about the degradation of TRIF
because overexpressed or activated TRIF forms inclusion
bodies [47]. Inclusion bodies are generally resistant to mild
detergents, and it is therefore possible that the TRIF deg-
radation was only attributable to formation of insoluble
inclusions. We therefore prepared cell lysates with the
strong detergent LDS, which is able to prevent generation
of insoluble protein precipitants. The results with Triton
X-100 and LDS were almost identical (Supplementary
material, Fig. S3).
As shown in Fig. 1b, the TRAF family member
TRAF6, but not TRAF3, is selectively degraded after
poly(I:C) stimulation in A20-silenced HeLa cells.
Unexpectedly, in HEK293T cells, we could observe
interaction of NDP52 with both TRAF6 and TRAF3 by
cotransfection of differently tagged versions followed by
IP and IB (Fig. 4c). Overexpression of TRAF6 with
NDP52 in HEK293T cells revealed that NDP52 could
degrade TRAF6, and the degradation was restored by
treatment with 3-MA (Fig. 4d). However, in contrast,
NDP52 hardly affected TRAF3 (Fig. 4e). Thus, NDP52
indeed mediates selective degradation of TRIF and
TRAF6.
NDP52 negatively regulates TLR-triggered
transcriptional activities of NF-jB and IRF3
Degradation of signaling molecules is generally thought to
be linked to downregulation of signal transduction. We
therefore investigated whether NDP52 is able to negatively
regulate TRIF-mediated signaling. In HEK293T cells,
transfection of NDP52 could attenuate the TRIF overex-
pression-induced transcriptional activities of NF-jB and
IRF3 (Fig. 5a, b). In addition, in HEK293 cells stably
expressing TLR4/MD-2, transfection of NDP52 attenuated
the LPS-induced activation of NF-jB and IRF3 (Fig. 5c,
d). Moreover, treatment of cells with 3-MA potentiated
TRIF-induced activation of NF-jB, and attenuated the
negative regulatory effect of NDP52 (Fig. 5e). In addition,
consistent with the result shown in Fig. 2h, silencing of
Beclin-1 did not affect the negative regulatory effect of
NDP52 (Fig. 5f). Thus, NDP52-mediated autophagic deg-
radation has a potential to negatively regulate TRIF-
mediated signaling.
The C-terminal region of NDP52 is required
for the activity of NDP52
Since NDP52 is a recently identiﬁed autophagy receptor
[31] ,i t sd e t a i l e df u n c t i o ni na u t o p h a g yi sl a r g e l y
unknown. NDP52 is a mainly cytosolic protein and is
ubiquitously expressed in various tissues and cells [48].
Human NDP52 was previously identiﬁed as a component
of the nuclear promyelocytic leukemia body [49]a n da
myosin VI-interacting molecule [50]. Two vertebrate
paralogs, COCOA/CALCOCO1 and TAX1BP1/CALCO-
CO3 (also known as T6BP), exist. Human NDP52
comprises an N-terminal skeletal muscle and kidney-
enriched inositol phosphatase carboxyl homology
( S K I C H )d o m a i n( a m i n oa c i ds 1–127), an intermediate
coiled-coil (CC) domain with a leucine zipper sequence
(amino acids 134–350) and a C-terminal Lin11, Isl-1 and
Mec-3 (LIM)-like domain (amino acids 395–446) that
consists of two zinc ﬁngers (Fig. 6a; Supplementary
material, Fig. S4). All domains of NDP52 are conserved
in humans, chimpanzees, bovines, dogs and chickens,
whereas mouse Ndp52 has a highly mutated CC domain
and completely lacks the LIM-like domain (Supplemen-
tary material, Fig. S4). Since it is suggested that the LIM-
like domain of human NDP52 speciﬁcally binds to
ubiquitin chains [31], the functions of NDP52 may be
considerably different in humans and mice. We investi-
gated which domain is required for the interaction and
degradation. Mapping of NDP52 revealed that the SKICH
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123domain was required for binding to TRIF (Fig. 6b). In
contrast, the LIM-like domain was required for the deg-
radation of TRIF (Fig. 6c). These results suggest that
NDP52 selectively interacts with activated TRIF through
the SKICH domain and subsequently recognizes their
polyUb through the LIM-like domain, followed by
induction of selective degradation. Although NDP52
lacking the SKICH domain (DSKICH) still had a degra-
dative effect on TRIF (Fig. 6c), in which the LIM-like
domain might be responsible for autophagic degradation,
we could not determine the reason. Importantly, trans-
fection of deletion mutants of NDP52 revealed that the
LIM-like domain was essential for the negative regula-
tory effect of NDP52 on TRIF signaling (Fig. 6d, e),
suggesting that the LIM-like domain-dependent protein
degradation results in suppression of TRIF-dependent
signaling.
NDP52 interacts with and degrades MyD88
We next examined whether or not the effect of NDP52 is
speciﬁc to the TRIF–TRAF6-dependent pathway because
TRAF6 is also involved in the MyD88-dependent path-
way. In HEK293T cells, we found that transfection of
NDP52 could attenuate the MyD88 overexpression-
induced transcriptional activities of NF-jB( S u p p l e -
mentary material, Fig. S5a). Also, in a way similar to
TRIF, NDP52 could degrade overexpressed MyD88
(Supplementary material, Fig. S5b), and the degradation
was restored by treatment with 3-MA (Supplementary
material, Fig. S5c). We also observed interaction of
MyD88 with NDP52 (Supplementary material, Fig. S5d).
Also, the SKICH domain of NDP52 was required for
binding to MyD88 (Supplementary material, Fig. S5e),
and the LIM-like domain was required for degradation of
MyD88 (data not shown). These results strongly suggest
that the effect of NDP52 is exerted not only on activated
TRIF but also on activated MyD88. Possibly, recruit-
ment of NDP52 to activated TRIF and MyD88 may be
mediated by TRAF6. Indeed, interaction of NDP52 with
TRAF6 was observed by cotransfection of differently
tagged versions followed by IP and IB (Fig. 4c). This
interaction was mediated by the SKICH domain of
NDP52 (data not shown). Thus, NDP52 is suggested to
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123be recruited to TRAF6 after activation of the two TLR
adaptor molecules, followed by induction of selective
autophagic degradation of these TLR adaptor-associated
signaling complexes.
NDP52 mediates aggregation of TRAF6
Autophagy receptors are known to mediate selective
aggregation of targets, and this process is required for
selective removal of them by autophagy [21]. We therefore
tested whether NDP52 is associated with TRAF6 aggre-
gation. Transfected TRAF6 hardly formed aggregates in
HeLa cells and was diffusedly present in the cytoplasm
(Fig. 7a, upper, and b). However, cotransfection of TRAF6
with NDP52 was found to be markedly increased in
aggregated TRAF6 in the cytoplasm, and the TRAF6
aggregates were colocalized with NDP52 (Fig. 7a, middle,
and b). NDP52-induced TRAF6 aggregates were detectable
as proteins with polyUb (Fig. 7c, middle and lower, and d),
although TRAF6 itself could sufﬁciently increase protein
aggregates with polyUb even in the absence of NDP52
transfection (Fig. 7c, upper, and d). In some cells, forma-
tion of autolysosome-like vacuoles was observed
(Fig. 7a, lower, and e, lower), and such vacuoles were
partly colocalized with the autolysosomal marker Rab7
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123(Fig. 7e, lower). Rab7-positive vacuoles hardly colocalized
with TRAF6 aggregations (Fig. 7e), suggesting that
TRAF6 may be rapidly degraded in Rab7-positive vacu-
oles. Transfection of TRAF6 with NDP52 did not
signiﬁcantly increase the formation of Rab7-positive vac-
uoles (Fig. 7f). We next tested whether A20 silencing
affects these observations. In A20-silenced HeLa cells,
NDP52-induced TRAF6 aggregates were clearly increased
(Fig. 7g, h). Aggregates of polyUb proteins were also
increased and TRAF6 aggregates were colocalized with
polyUb of proteins (Fig. 7i, j). Under the condition of A20
silencing, autolysosome-like vacuoles were increased and
partly colocalized with Rab7 (Fig. 7k, l). These results
collectively suggest that, after recruitment to TRAF6,
NDP52 participates in the aggregation of the TRAF6
conjugated with polyubiquitin chains. This process may
lead to degradation of TRAF6 in autolysosome although
such a function of NDP52 is restricted by A20.
NDP52 undergoes Lys63- and Lys48-linked polyUb
by TRAF6
We next asked how NDP52 aggregates TRAF6. Intracel-
lular protein aggregation is generally thought to be linked
to accumulation of polyubiquitinated proteins in the cyto-
plasm [20]. Polymerization of the polyubiquitinated
proteins results in the formation of microscopically visible
structures known as inclusion bodies and aggresomes [20].
We tested whether NDP52 undergoes polyUb by TRAF6.
We found that overexpression of NDP52 with TRAF6
resulted in appearance of shifted bands of NDP52 with
higher molecular weights (Fig. 8a). Also, overexpression
of NDP52 with TRIF or with MyD88 resulted in appear-
ance of shifted bands (Fig. 8b). TRAF3 exerted a similar
Fig. 7 NDP52 promotes aggregation of TRAF6. a, c, e, g, i, k HeLa
cells were transfected with Flag-TRAF6 and HA-NDP52 for 24 h (a,
c, e). HeLa cells were transfected with control siRNA or A20 siRNA
for 24 h. Then cells were further transfected with HA-NDP52 and
Flag-TRAF6 for 18 h (g, i, k). Cells were ﬁxed and stained with anti-
Flag mouse monoclonal antibody and Alexa564-conjugated anti-
mouse IgG antibody and then with anti-NDP52 rabbit polyclonal
antibody and Alexa488-conjugated anti-rabbit IgG antibody (a, g),
with anti-TRAF6 rabbit polyclonal antibody and Alexa488-conju-
gated anti-rabbit IgG antibody and then with anti-FK2 mouse
monoclonal antibody and Alexa564-conjugated anti-mouse IgG
antibody (c, i) or with anti-Flag mouse monoclonal antibody and
Alexa564-conjugated anti-mouse IgG antibody and then with anti-
Rab7 rabbit monoclonal antibody and Alexa488-conjugated anti-
rabbit IgG antibody (e, k). Arrows autolysosome-like vesicles. Scale
bar 10 lm. b, d, f, h, j, l Quantiﬁcation of the percentage of cells
containing TRAF6 aggregates (b, h), polyUb aggregates (d, j), and
Rab7-positive vesicles (f, l) were performed by counting Flag-
TRAF6-positive cells on ﬁve different images of microscopic ﬁelds
including at least 30 cells. Results, shown as the mean ± SD (n = 5),
are representative of three independent experiments. *P\0.01
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123effect, but it was very weak (Fig. 8b). Importantly, an IP
study revealed that TRAF6 yielded both Lys63- and Lys48-
linked polyUb of NDP52 (Fig. 8c). Although TRAF3 had a
similar activity, it was very weak (Fig. 8c). Of note, under
the condition of A20 silencing, only Lys48-linked polyUb
of NDP52 by TRAF6 were increased (Fig. 8d). Thus,
NDP52 undergoes polyUb by TRAF6, which may be
involved in promotion of TRAF6 aggregation.
A20 controls negative regulation of proinﬂammatory
responses by NDP52
This study suggests a possibility that the autophagy receptor
NDP52 exerts a negative regulatory effect on TLR-induced
proinﬂammatoryresponsesthroughdegradationofactivated
TLR adaptor molecules and TRAF6. However, this effect
may be normally inactivated by A20. To verify this, we
investigated the effect of silencing of NDP52 together with
A20 by siRNA. In HeLa cells, poly(I:C) induced mRNA
expression of IL-6, IL-8 and A20 and the IRF3-responsible
gene CXCL10 (Fig. 9). Expression of NDP52 was not
clearlyaffectedbypoly(I:C)stimulation(Fig. 9).Compared
with the control cells, silencing of NDP52 hardly affected
mRNA expression of IL-6, IL-8 and CXCL10 (Fig. 9).
Interestingly, silencing of the combination of A20/NDP52
promoted the induction of gene expression of IL-6, IL-8 and
CXCL10 (Fig. 9). Thus, A20 indeed serves as a negative
regulator for the negative regulatory effect of NDP52.
Discussion
The critical link between pathogen recognition of TLRs
and autophagy has been shown [22–24], but it is largely
unknown whether autophagy receptors have any regulatory
effects on TLR signaling. In this study, we identiﬁed an
unanticipated mechanism, in which the autophagy receptor
NDP52 works downstream of TLR adaptors to negatively
regulate TLR signaling. NDP52 seems to promote TRAF6
aggregation that is required for the selective degradation of
TLR adaptor-associated signaling complex in a non-
canonical autophagy-dependent manner. Thus, TRAF6 and
NDP52 can cooperatively suppress TLR signal transduc-
tion. In addition, A20 downregulates the activity of NDP52
probably through suppression of polyUb by TRAF6. This
may be related to the previous ﬁnding that TRAF6 induc-
tion of Lys63-linked polyUb of Beclin-1 is negatively
regulated by A20 [51]. Although biological signiﬁcance of
the presence of such complicated mechanisms for negative
regulation of TLR signaling by A20 and NDP52 is obscure,
NDP52 may preferentially work to suppress excess TLR
signaling in the case of the absence or an insufﬁcient
expression level of A20.
NDP52 mediates selective autophagic degradation of
TRIF and TRAF6 after TLR signal transduction. This type
of autophagy could be suppressed by the autophagy
inhibitor 3-MA, but was not associated with ‘canonical’
autophagic mechanisms, such as conversion of LC3-I to
LC3-II and involvement of Beclin-1 and ATG proteins.
Given that 3-MA is an inhibitor for class III PI3 kinase,
induction of autophagy found in this study is at least
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123dependent on PI3 kinase. Although we could not determine
the reason why this type of autophagy does not depend on
Beclin-1 and ATG proteins, several recent reports have
shown existence of non-canonical autophagy, the process
of which does not require these proteins [27, 29]. Recently,
such autophagy was found to be mediated by the anti-
apoptotic protein Bcl-xL [28]. NDP52-mediated autophagy
may also be activated by Bcl-xL.
NDP52 negatively regulates not only NF-jB activation
downstream of TRAF6 but also IRF3 activation down-
stream of TRAF3 (Fig. 5). In addition, NDP52 can
physically bind TRAF6 and TRAF3 (Fig. 4c). However,
NDP52 can speciﬁcally degrade TRAF6, but not TRAF3
(Fig. 4d, e). Therefore, NDP52 has differential biological
functions for binding and regulation of degradation
between TRAF6 and TRAF3. TRAF6 ubiquitinates NDP52
possibly through the interaction with NDP52 (Fig. 8c),
which ultimately leads to induction of TRAF6 aggregation
(Fig. 7). TRIF may be involved in this process through the
TRIF–TRAF6 interaction and may be selectively degraded
together with TRAF6 through selective autophagy. This
process may lead to suppression of TLR- and TRAF6-
mediated NF-jB activation. In contrast to TRAF6, TRAF3
hardly ubiquitinates NDP52 (Fig. 8c) although NDP52 can
physically bind TRAF3. A previous report indicated that
NDP52 exerts different effects on TLR signaling down-
stream of TRAF3, in which NDP52 may work as an
adaptor molecule for the TRAF3 downstream molecule
TBK1 [31]. This observation suggests that TRAF3 requires
NDP52 to induce appropriate activation of downstream
TBK1–IRF3 signaling. The reason why NDP52 could
suppress IRF3 activation may be caused by NDP52-induced
decreaseofTRIF. InTLR signaling, TRAF3 activation never
occurs in the absence of TRIF.
A20 is known to act not only as a deubiquitinase for the
targets with Lys63-linked polyUb but also as an E3 ubiq-
uitin ligase to catalyse Lys48-linked polyUb [14]. In our
study, A20 was at least involved in the regulation of Lys48-
linked polyUb of NDP52, which may be dependent on
suppression of TRAF6-induced Lys48-linked polyUb
(Fig. 8d). However, we could not clearly see the implica-
tion of A20 in catalysis of Lys63-linked Ub of NDP52
(Fig. 8d). A recent report has shown an additional mech-
anism of A20 for substrate inactivation, whereby A20
disrupts the interaction of an E3 ubiquitin ligase with a
substrate or of an E2 ubiquitin-conjugating enzyme with an
E3 ubiquitin ligase, leading to attenuation of the activation
of speciﬁc E3 ubiquitin ligases, such as TRAF6 [16].
Therefore, it is possible that this mechanism of A20 is
preferentially involved in the TRAF6 regulation of NDP52
and that NDP52 is not a substrate of A20.
NDP52/CALCOCO2 and TAX1BP1/CALCOCO3 are
paralogs of COCOA/CALCOCO1. These molecules share
the CALCOCO domain that consists of the N-terminal
SKICH domain and the subsequent CC domain. TAX1BP1
is a TRAF6-binding molecule [52] and negatively regulates
TRAF6-induced NF-jB activation through assistance of
the function of A20 and the E3 ubiquitin ligase Itch [16,
53]. Such a function of TAX1BP1 is intrinsically different
from the function of NDP52 that is associated with selec-
tive autophagy downstream of TRAF6. Since TAX1BP1
works together with A20, it is possible that TAX1BP1
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123negatively regulates the function of NDP52. TAX1BP1 has
C-terminal zinc ﬁngers that contain two Pro-Pro-X-Tyr
motifs, which are essential for the negative regulatory
effect on NF-jB signaling [53], while NDP52 and COCOA
do not have such motifs in the C-terminal ends (Supple-
mentary material, Fig. S6). The C-terminal LIM-like
domain of NDP52 mediates the recognition of ubiquitin
chains [31] and is analogous to the N-terminal regions of
CRP, CRIP1 and CRIP2 [49] (Supplementary material,
Fig. S6). Therefore, each structure of the C-terminal end
may be responsible for the different functions of TAX1BP1
and NDP52. Also, TAX1BP1 has an atypical TRAF6-
binding motif, Pro-X-Glu-X-X-X-[Aromatic (Ar) or acidic
(Ac) amino acid] [54], corresponding to the sequence
PAERKME (597–603 amino acids) (but not a typical
TRAF6-binding motif, Pro-X-Glu-X-X-(Ar/Ac) [55]).
NDP52 does not have any TRAF6-binding motifs, sug-
gesting that the interaction of NDP52 with TRAF6 may be
indirect. However, the long and short of it is that
TAX1BP1 and NDP52 share the function to negatively
regulate TRAF6-mediated signaling. It is also possible that
COCOA negatively regulates TRAF6-mediated signaling
through an unknown mechanism.
Initially, it was reported that TLR4 recognition of LPS
induces autophagy through TRIF but not MyD88 [24].
After that, recognition of poly(I:C) by TLR3 was shown to
trigger autophagy through TRIF, while recognition of im-
iquimod by TLR7 induces autophagy through MyD88 [22].
It was also reported that both TRIF and MyD88 interact
with Beclin1 and induce autophagy [56]. In this study, we
obtained several lines of evidence that activated TRIF and
MyD88 recruit the autophagy receptor NDP52 to trigger
aggregation of signaling complexes involving TRAF6, in
which the activity of NDP52 may be regulated by TRAF6
through polyUb (Fig. 8). NDP52 probably recognizes
Lys63-linked polyUb of TRIF, MyD88 and TRAF6
through the LIM-like domain (Fig. 6) and is subsequently
involved in the aggregation of them in the cytoplasm. This
process does not stimulate induction of canonical autoph-
agy ﬂux but can selectively facilitate TLR signaling
molecules to yield selective autophagic degradation prob-
ably in a non-canonical autophagy-dependent manner. The
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Fig. 10 Schematic of regulation of TLR signaling by NDP52 under
the control of A20. TLR triggering activates signaling pathways via
two key adaptor molecules, MyD88 and TRIF. MyD88 interacts with
TRAF6 that catalyses Lys63-linked polyUb of target proteins, leading
to activation of downstream NF-jB signaling. TRIF is also able to
activate TRAF6-dependent signaling. In addition, TRIF activates
TRAF3-dependent signaling that catalyses Lys63-linked polyUb of
target proteins, which mediates IRF3 signaling. a In the presence of
A20, this enzyme cleaves Lys63-linked polyubiquitin chains, leading
to negative regulation of TRAF6-mediated activation of NF-jB and
TRAF3-mediated activation of IRF3. A20 further promotes catalyses
of Lys48-linked polyUb of target proteins, including MyD88 and
TRIF, which may lead to their proteasomal degradation. In addition,
A20 is thought to suppress induction of autophagy [51]. Although
NDP52 has a potential to be activated by TRAF6 to mediate selective
autophagy, A20 normally inactivates NDP52 through deubiquitina-
tion. b In the absence of A20, NDP52 may be fully activated by
TRAF6. In this case, NDP52 can mediate aggregation of the
complexes of MyD88–TRAF6 and TRIF–TRAF6. This process is
thought to be important to selectively degrade unnecessary signaling
molecules in lysosomes via an autophagic mechanism. This type of
autophagy seems to be induced through non-canonical processes.
Such a function of NDP52-mediated autophagy ultimately leads to
negative regulation of TLR signaling
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123principal functions of NDP52 found in this study are
summarized in Fig. 10.
Beyond its critical function of cell-autonomous protec-
tion from starvation, autophagy assumes the responsibility
of regulation of innate immune responses [26, 57]. The
most well-known function is selective elimination of
intracellular pathogens, including bacteria and viruses.
Recently, it is becoming clear that several autophagy
receptors, including NDP52 and SQSTM1, play an impor-
tant role in the selective elimination of pathogenic bacteria
[21, 31, 58]. During this, autophagy seems to be useful for
cytoprotection towards excess innate immune signaling
that often generates a cytotoxic level of ROS [59, 60]. Our
results regarding the functions of NDP52 for negative
regulation of TLR signaling support this idea. On the other
hand, recent ﬁndings from the analyses of gene knockout
mice have revealed that certain autophagy receptors,
including SQSTM1 and NBR1, are involved in T helper
type 2 cell differentiation [61, 62]. Therefore, autophagy
receptor-mediated negative regulation of TLR signal-
ing may be involved in effective induction of acquired
immunity. Future investigations should reveal unknown
functions of autophagy receptors in innate and adaptive
immunity, which may be found to be under the control of
A20.
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